Cerebrospinal fluid cell-free DNA sequencing in pediatric CNS tumors: towards liquid molecular neuropathology
Authors:
- William GehinWGWilliam Gehin
- Marie-Sophie MerlinMMMarie-Sophie Merlin
- Alexandre HarleAHAlexandre Harle
- Jean-Louis MerlinJMJean-Louis Merlin
Open Access
- 10 August 2026
- journal article
- Published by Springer Nature in Acta Neuropathologica
- Vol. 152 (1)
Abstract
No abstract availableThis publication has 67 references indexed in Scilit:
- Detection of H3F3A K27M or BRAF V600E in liquid biopsies of brain tumor patients as diagnostic and monitoring biomarker: impact of tumor localization and sampling methodActa Neuropathologica, 2025
- Methylation profiling of plasma cell-free DNA in pediatric brain tumor patientsActa Neuropathologica, 2024
- Detection of tumor-derived cell-free DNA in cerebrospinal fluid using a clinically validated targeted sequencing panel for pediatric brain tumorsJournal of Neuro-Oncology, 2024
- 2. Personalized sequencing assays for cerebrospinal fluid liquid biopsies in children with brain tumorsCancer Genetics, 2023
- Clinical applicability of miR517a detection in liquid biopsies of ETMR patientsActa Neuropathologica, 2023
- Rapid-CNS2: rapid comprehensive adaptive nanopore-sequencing of CNS tumors, a proof-of-concept studyActa Neuropathologica, 2022
- Serial assessment of measurable residual disease in medulloblastoma liquid biopsiesCancer Cell, 2021
- Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypesActa Neuropathologica, 2019
- Intertumoral Heterogeneity within Medulloblastoma SubgroupsCancer Cell, 2017
- Proteomic analyses of CSF aimed at biomarker development for pediatric brain tumorsJournal of Neuro-Oncology, 2014